Perit Dial Int
26(2):
266-275
2006
© 2006 International Society for Peritoneal Dialysis
THE SUCCESS STORY OF PERITONEAL DIALYSIS IN ROMANIA: ANALYSIS OF DIFFERENCES IN MORTALITY BY DIALYSIS MODALITY AND INFLUENCE OF RISK FACTORS IN A NATIONAL COHORT
Gabriel Mircescu1,3,
Liliana Garneata1,
Laura Florea2,
Vasile Cepoi2,
Dimitrie Capsa3,
Maria Covic2,3,
Mirela Gherman-Caprioara3,
Gheorghe Gluhovschi3,
Ovidiu Sorin Golea3,
Carmen Barbulescu1,
Elvira Rus1,
Caterina Santimbrean1,
Nicoleta Mardare2 and
Adrian Covic2,3
"Dr Carol Davila" Teaching Hospital of
Nephrology,1 Bucharest; Dialysis and
Transplantation Center,2 "C.I.
Parhon" University Hospital, Iasi; Romanian Renal
Registry,3 Romania
Correspondence to: A. Covic, Nephrology, C.I. Parhon University Hospital,
Blvd. Carol 1st No. 50, Iasi 700503,
Romania.
Romania.acovic{at}xnet.ro
- Background: This report describes the status of renal
replacement therapy (RRT), particularly continuous ambulatory peritoneal
dialysis (CAPD), in Romania (a country with previously limited facilities),
outlines the fast development rate of CAPD, and presents national changes in a
European context.
- Methods: Trends in the development of RRT were analyzed in 2003
on a national basis using annual center questionnaires from 1995 to 2003.
Survival data and prognostic risk factors were calculated retrospectively from
a representative sample of 2284 patients starting RRT between 1 January 1995
and 31 December 2001 (44% of the total RRT population investigated).
- Results: The annual rate of increase in the number of RRT
patients (11%) was supported mainly by an exponential development of the CAPD
population (+600%); the hemodialysis (HD) growth rate was stable (+33%) and
renal transplantation had a marginal contribution. The characteristics of both
HD and PD incident patients changed according to current European epidemiology
(increasing age and prevalence of diabetes and nephroangiosclerosis). There
were significant differences between PD and HD incident populations, PD
patients being significantly older and having a higher prevalence of diabetic
nephropathy and baseline comorbidities, probably reflecting different
inclusion policies. The estimated overall survival of RRT patients in Romania
was 90.6% at 1 year [confidence interval (CI) 89.4-91.8] and 62.2% at 5 years
(CI 59.4-65.0). The initial treatment modality did not significantly influence
patients' survival. There was no difference in unadjusted technique survival
during the first 2 years; afterwards, there was a clear advantage for HD, with
more patients being transferred from PD to HD. Several factors seemed to
significantly and negatively influence PD patients' survival (Cox regression
analysis): male gender, lack of predialysis erythropoietin treatment, and
initial comorbidities. Stratified analysis to discover the influence of these
factors on patients' survival revealed that HD was associated with an
increased risk of death in the younger nondiabetic end-stage renal disease
population, regardless of other coexisting comorbid conditions. However, in
older patients (>65 years) and in diabetics, regardless of the presence or
absence of associated comorbid conditions, there was no significant difference
in death rates between HD and PD patients.
- Conclusions: We report an impressive quantitative and
qualitative development of CAPD in one of the rapidly growing Central and
Eastern Europe countries. CAPD should be the method of choice for young
nondiabetic end-stage renal disease patients. Improvement in predialysis
nephrologic care and in transplantation rates is required to further ensure
the ultimate success of the Romanian PD program.
KEY WORDS: Survival; technique survival; death rate.
Received 3 May 2005;
accepted 25 August 2005.
This article has been cited by other articles:

|
 |

|
 |
 
M. Mahdavi-Mazdeh, M. Zamyadi, and M. Nafar
Assessment of management and treatment responses in haemodialysis patients from Tehran province, Iran
Nephrol. Dial. Transplant.,
January 1, 2008;
23(1):
288 - 293.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by Multimed Inc.